Literature DB >> 19906071

Primary cutaneous B-cell lymphoma is associated with somatically hypermutated immunoglobulin variable genes and frequent use of VH1-69 and VH4-59 segments.

M Perez1, A Pacchiarotti, M Frontani, E Pescarmona, E Caprini, G A Lombardo, G Russo, T Faraggiana.   

Abstract

BACKGROUND: Accurate assessment of the somatic mutational status of clonal immunoglobulin variable region (IgV) genes is relevant in elucidating tumour cell origin in B-cell lymphoma; virgin B cells bear unmutated IgV genes, while germinal centre and postfollicular B cells carry mutated IgV genes. Furthermore, biases in the IgV repertoire and distribution pattern of somatic mutations indicate a possible antigen role in the pathogenesis of B-cell malignancies.
OBJECTIVES: This work investigates the cellular origin and antigenic selection in primary cutaneous B-cell lymphoma (PCBCL).
METHODS: We analysed the nucleotide sequence of clonal IgV heavy-chain gene (IgVH) rearrangements in 51 cases of PCBCL (25 follicle centre, 19 marginal zone and seven diffuse large B-cell lymphoma, leg-type) and compared IgVH sequences with their closest germline segment in the GenBank database. Molecular data were then correlated with histopathological features.
RESULTS: We showed that all but one of the 51 IgVH sequences analysed exhibited extensive somatic hypermutations. The detected mutation rate ranged from 1.6% to 21%, with a median rate of 9.8% and was independent of PCBCL histotype. Calculation of antigen-selection pressure showed that 39% of the mutated IgVH genes displayed a number of replacement mutations and silent mutations in a pattern consistent with antigenic selection. Furthermore, two segments, VH1-69 (12%) and VH4-59 (14%), were preferentially used in our case series.
CONCLUSIONS: Data indicate that neoplastic B cells of PBCBL have experienced germinal centre reaction and also suggest that the involvement of IgVH genes is not entirely random in PCBCL and that common antigen epitopes could be pathologically relevant in cutaneous lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906071     DOI: 10.1111/j.1365-2133.2009.09576.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

Review 1.  [Treatment of indolent cutaneous B‑cell lymphoma].

Authors:  M Wobser
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

Review 2.  Dermatological Considerations in the Diagnosis and Treatment of Marginal Zone Lymphomas.

Authors:  Andrea Ronchi; Antonello Sica; Paola Vitiello; Renato Franco
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-03-08

3.  The role of molecular pathology in the diagnosis of cutaneous lymphomas.

Authors:  Philipp W Raess; Adam Bagg
Journal:  Patholog Res Int       Date:  2012-11-19

4.  Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein.

Authors:  Valentine U Chukwuma; Mark D Hicar; Xuemin Chen; Katherine J Nicholas; Amanda Joyner; Spyros A Kalams; Gary Landucci; Donald N Forthal; Paul W Spearman; James E Crowe
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

5.  The immunosignature of canine lymphoma: characterization and diagnostic application.

Authors:  Stephen Albert Johnston; Douglas H Thamm; Joseph Barten Legutki
Journal:  BMC Cancer       Date:  2014-09-08       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.